ACRV Insider Trading Activity and SEC Form 4 Filings
ACRV insider trading summary
Over the past 12 months, insiders at Acrivon Therapeutics, Inc. (ACRV) reported 13 sales worth $74K by 6 insiders and 4 open-market purchases worth $196K by 4 insiders on SEC Form 4. Net insider buying was $123K.
Latest ACRV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 22, 2026 | Mary Miller | Chief Legal Officer | Sell | $944 (513 @ $1.84) |
| Oct 5, 2026 | Mary Miller | Chief Legal Officer | Sell | $585 (294 @ $1.99) |
| Aug 25, 2026 | Peter Blume-Jensen | President and CEO | Sell | $31K (14,036 @ $2.21) |
| Aug 25, 2026 | Kristina Masson | EVP - Business Operations | Sell | $31K (14,036 @ $2.21) |
| Aug 18, 2026 | Kristina Masson | EVP - Business Operations | Sell | $973 (484 @ $2.01) |
| Aug 18, 2026 | Peter Blume-Jensen | President and CEO | Sell | $973 (484 @ $2.01) |
| Aug 18, 2026 | Erick Gamelin | Chief Development Officer | Sell | $804 (400 @ $2.01) |
| Aug 18, 2026 | Mary Miller | Chief Legal Officer | Sell | $372 (185 @ $2.01) |
| Aug 18, 2026 | Peter Blume-Jensen | President and CEO | Sell | $2K (1,229 @ $2.01) |
| Aug 18, 2026 | Kristina Masson | EVP - Business Operations | Sell | $2K (1,229 @ $2.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.